Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 2
1976 2
1981 1
1984 2
1985 1
1987 1
1989 1
1990 3
1992 2
1993 2
1994 2
1995 4
1996 2
1997 8
1998 7
1999 8
2000 10
2001 11
2002 19
2003 16
2004 26
2005 16
2006 20
2007 18
2008 20
2009 21
2010 20
2011 28
2012 20
2013 24
2014 25
2015 29
2016 8
2017 19
2018 21
2019 20
2020 24
2021 24
2022 26
2023 22
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

493 results

Results by year

Filters applied: . Clear all
Page 1
Foreword.
Ishida T, Kawakami S, Hosoya KI. Ishida T, et al. Among authors: hosoya ki. Biol Pharm Bull. 2020;43(4):575. doi: 10.1248/bpb.b20-ctf4304. Biol Pharm Bull. 2020. PMID: 32238699 Free article. No abstract available.
Retrospective study of feline tracheal mass lesions.
Kanemoto H, Fujiwara-Igarashi A, Kobayashi T, Harada K, Ichimata M, Kim S, Hosoya K, Tomiyasu H, Ohmi A, Tsujimoto H. Kanemoto H, et al. Among authors: hosoya k. J Feline Med Surg. 2023 May;25(5):1098612X231164611. doi: 10.1177/1098612X231164611. J Feline Med Surg. 2023. PMID: 37199684 Free article.
Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer.
Katayama Y, Yamada T, Tanimura K, Tokuda S, Morimoto K, Hirai S, Matsui Y, Nakamura R, Ishida M, Kawachi H, Yoneda K, Hosoya K, Tsuji T, Ozasa H, Yoshimura A, Iwasaku M, Kim YH, Horinaka M, Sakai T, Utsumi T, Shiotsu S, Takeda T, Katayama R, Takayama K. Katayama Y, et al. Among authors: hosoya k. NPJ Precis Oncol. 2023 Jan 26;7(1):12. doi: 10.1038/s41698-023-00350-7. NPJ Precis Oncol. 2023. PMID: 36702855 Free PMC article.
Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation-positive Lung Cancer.
Ogimoto T, Ozasa H, Tsuji T, Funazo T, Yamazoe M, Hashimoto K, Yoshida H, Hosoya K, Ajimizu H, Nomizo T, Yoshida H, Hamaji M, Menju T, Yoshizawa A, Date H, Hirai T. Ogimoto T, et al. Among authors: hosoya k. Mol Cancer Ther. 2024 Apr 2;23(4):564-576. doi: 10.1158/1535-7163.MCT-23-0371. Mol Cancer Ther. 2024. PMID: 38052760
Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
Maekawa N, Konnai S, Hosoya K, Kim S, Kinoshita R, Deguchi T, Owaki R, Tachibana Y, Yokokawa M, Takeuchi H, Kagawa Y, Takagi S, Ohta H, Kato Y, Yamamoto S, Yamamoto K, Suzuki Y, Okagawa T, Murata S, Ohashi K. Maekawa N, et al. Among authors: hosoya k. PLoS One. 2023 Oct 4;18(10):e0291727. doi: 10.1371/journal.pone.0291727. eCollection 2023. PLoS One. 2023. PMID: 37792729 Free PMC article.
Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study.
Hosoya K, Komachi T, Masaki K, Suzaki I, Saeki H, Kanda N, Nozaki M, Kamide Y, Matsuwaki Y, Kobayashi Y, Ogino E, Osada SI, Usukura N, Kurumagawa T, Ninomia J, Asako M, Nakamoto K, Yokoi H, Ohyama M, Tanese K, Kanzaki S, Fukunaga K, Ebisawa M, Okubo K. Hosoya K, et al. Patient Prefer Adherence. 2023 Mar 27;17:861-872. doi: 10.2147/PPA.S389865. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 37009430 Free PMC article.
493 results